Host: |
Goat |
Applications: |
Pep-ELISA/WB/IF/FC |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Goat polyclonal antibody anti-WISP1 (C-Term) is suitable for use in ELISA, Western Blot, Immunofluorescence and Flow Cytometry research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA |
Purification: |
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. |
Concentration: |
0.5 mg/mL |
Dilution Range: |
WB-0.1-0.3µg/mlELISA-antibody detection limit dilution 1:128000. |
Storage Instruction: |
Store at-20°C on receipt and minimise freeze-thaw cycles. |
Gene Symbol: |
CCN4 |
Gene ID: |
8840 |
Uniprot ID: |
CCN4_HUMAN |
Immunogen Region: |
C-Term |
Accession Number: |
NP_003873.1; NP_543028.1 |
Specificity: |
This antibody is expected to recognize both reported isoforms (NP_003873.1; NP_543028.1). |
Immunogen Sequence: |
ESYPDFSEIAN |
Function | Downstream regulator in the Wnt/Frizzled-signaling pathway. Associated with cell survival. Attenuates p53-mediated apoptosis in response to DNA damage through activation of AKT kinase. Up-regulates the anti-apoptotic Bcl-X(L) protein. Adheres to skin and melanoma fibroblasts. In vitro binding to skin fibroblasts occurs through the proteoglycans, decorin and biglycan. |
Protein Name | Ccn Family Member 4Wnt1-Inducible-Signaling Pathway Protein 1Wisp-1Wnt-1-Induced Secreted Protein |
Cellular Localisation | Secreted |
Alternative Antibody Names | Anti-Ccn Family Member 4 antibodyAnti-Wnt1-Inducible-Signaling Pathway Protein 1 antibodyAnti-Wisp-1 antibodyAnti-Wnt-1-Induced Secreted Protein antibodyAnti-CCN4 antibodyAnti-WISP1 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance